Related by context. All words. (Click for frequent words.) 70 nucleotide analog 69 pyrimidine nucleoside analog 65 HCV RNA polymerase 65 NS5b 65 investigational integrase inhibitor 64 agonistic human 64 oral ghrelin agonist 63 Initiates Phase II 63 Achieves Primary Endpoint 63 Entry Inhibitor 63 proprietary BiTE ® 63 non nucleoside inhibitor 63 AKT inhibitor 63 NS5B polymerase 63 LymphoStat B TM 63 cytidine nucleoside analog 63 pharmacogenomic translational research 63 anti botulism antibody 63 LymphoStat B belimumab 63 Fc fusion protein 63 Hsp# Inhibitor 62 additional purine nucleotide 62 Submits IND 62 Prodarsan R 62 Initiate Clinical Trial 62 selectively inhibit replication 62 Presents Preclinical Data 62 IMiDs ® 62 Initiates Enrollment 62 systemic RNAi therapeutic 62 Alfacell proprietary ribonuclease 62 Hepatitis C Virus HCV 62 MVA HPV IL2 62 vinorelbine tartrate 62 treatment naïve genotype 62 humanized monoclonal antibodies 62 intranasal formulation 62 TM Aganocide 62 CYT# potent vascular disrupting 62 apricitabine ATC 62 nasal decolonization 62 methylnaltrexone bromide 62 introduced NEUGENE 62 proprietary intranasal insulin 62 biased ligand 62 SinuNase ™ 62 CCR5 antagonist 62 Begins Dosing 62 nucleoside analog 61 toenail onychomycosis 61 attach auristatin 61 polymerase inhibitor 61 oral Hsp# inhibitor 61 targeted radiotherapeutic 61 non nucleoside 61 HCV NS5B polymerase 61 ATRA IV 61 investigational protease inhibitor 61 Vaxfectin formulated 61 NS3 protease 61 AAG geldanamycin analog 61 Spiegelmer ® 61 Investigational Oral 61 PEGylated anti 61 liposomal formulation 61 candidates Azedra TM 61 FOLOTYN ® 61 novel emulsion formulation 61 subcutaneous immunoglobulin 61 ChronVac C R 61 Vitrasert R 61 novel therapeutic antibodies 61 developing Zerenex ferric 61 retaspimycin hydrochloride 61 virosome 61 Elvitegravir 61 receptor tyrosine kinase inhibitor 61 liposomal delivery 61 Gets FDA Clearance 61 Vicriviroc 61 Daclizumab 61 anionic backbone 61 Genotyping Test 61 Crucell genetically engineered 61 Therapeutic Competitors Companies 60 BiTE R 60 molecular imaging radiopharmaceutical 60 Shigatoxin producing E. coli 60 kidney urologic 60 topical gel formulation 60 Thiovir 60 CYP#A# CYP#D# 60 lipopeptide 60 hyaluronidase enzyme 60 personalized dendritic 60 personalized immunotherapy 60 Prodarsan ® 60 NS#/#A protease 60 XmAb ® 60 VEGFR2 inhibitor 60 gets USFDA nod 60 TLR9 agonist 60 humanized monoclonal 60 Completes Patient Enrollment 60 chimeric monoclonal antibody 60 OncoVex 60 HCV polymerase 60 SPL# Gel vaginal microbicide 60 pegylated recombinant 60 pathophysiological effects 60 PNP inhibitor 60 ALN HPN 60 TransVax tm 60 HuMax TAC 60 immunotherapeutic vaccine 60 systemically administered 60 acid phosphatase PAP 60 oncolytic virus therapies 60 Polymerase Inhibitor 60 Initiates Clinical 60 small molecule tyrosine 60 vapreotide acetate 60 virus HCV protease inhibitor 60 Amgen Neulasta ® 60 potently inhibit 60 hemagglutination inhibition HAI 60 JAK2 Inhibitor 60 plasmid DNA pDNA 60 NS5A inhibitor 60 oral prodrug 60 MVA BN R 60 Receives Orphan Drug Designation 60 mertansine 60 Pharmacokinetics PK 60 Belerofon 60 Anidulafungin 60 Atripla combines 60 rusalatide acetate 60 DepoVax TM 60 COBAS R 60 orally administered inhibitor 60 MKC# MT 60 Adenoviral 60 albumin bound paclitaxel 60 Monoclonal antibody 60 MCSP respectively 60 proprietary radiolabeled monoclonal 60 Amgen Neulasta R 60 Onalta ™ 60 antibody MAb 60 phosphatidylserine PS targeting 60 DURIN TM 60 selective immunoproteasome inhibitor 60 virus AAV 60 orally inhaled migraine 60 oropharyngeal candidiasis OPC 60 include Altastaph TM 59 IAP inhibitor 59 Saquinavir 59 HepDirect prodrug 59 RTP #i 59 Ecallantide 59 anti CD3 monoclonal 59 evaluating tivozanib 59 Inc. www.micromet inc.com 59 Files IND 59 oral Janus kinase 59 essential thrombocythemia ET 59 Nitazoxanide 59 DG# compounds targeting 59 Initiates Dosing 59 inhalation powder 59 TransVax TM 59 Mg Usa 59 initiated Phase Ib 59 lipoglycopeptide 59 platform HDL Mimetic 59 using VIAdel TM 59 ESBA# 59 Transdrug R 59 investigational oral hepatitis C 59 receptor activator 59 Initiate Phase 59 Initiates Clinical Trial 59 PI3K/Akt pathway inhibitor 59 interferon alpha IFN 59 highly selective endothelin 59 Kinase Inhibitor 59 GVAX ® 59 PEGylated interferon 59 Emtriva Viread 59 thrombin component 59 Zalypsis 59 small molecule activators 59 Pruvel ™ 59 compound perifosine 59 triciribine phosphate monohydrate 59 non porcine pancreatic 59 rxRNA 59 Vascular Disrupting Agent 59 oral dihydropyrimidine dehydrogenase DPD 59 lumiliximab 59 Initiates Phase 2b 59 orally dosed 59 virus HCV 59 monoclonal antibody MAb 59 adecatumumab MT# 59 Inotek Pharmaceuticals Corporation 59 radiation sensitizer 59 telaprevir VX 59 hepatitis C HCV 59 LAB CGRP 59 Peginterferon alfa 2b 59 Reports Preclinical Data 59 potently inhibits 59 histone deacetylase HDAC inhibitor 59 DermaVir Patch 59 ® bortezomib 59 mda 7 59 Genentech sanofi aventis 59 Mg Uk 59 humanized therapeutic 59 Intravenous Human 59 Alferon N 59 Integrase Inhibitor 59 ADP receptor antagonist 59 5 HT3 antagonist 59 Factor VIIa 59 BrachySil ™ 59 lipid nanoparticle 59 Granulocyte Colony Stimulating Factor 59 highly selective inhibitor 59 novel VDA molecule 59 platinum chemotherapeutic 59 Albuferon TM 59 Pruvel TM 59 Topoisomerase II 59 5 HT2A serotonin 59 selective modulator 59 Small Modular SMIP 59 oral nucleoside analogue 58 CCR9 antagonist 58 targeting CD# 58 castrate resistant prostate cancer 58 candidate XP# 58 mediated inhibition 58 MAGE A3 ASCI 58 accumulate preferentially 58 Provectus Pharmaceuticals specializes 58 Temsirolimus 58 intranasal insulin product 58 small molecule glucokinase 58 Solazed TM 58 patients coinfected 58 potently inhibited 58 anti PlGF 58 Aflibercept 58 Crofelemer budesonide foam 58 humanised monoclonal antibody 58 SinuNase TM 58 IMiDs R 58 p# inhibitor 58 e antigen HBeAg 58 anti infective treatments 58 Liposomal 58 immune globulin intravenous 58 miconazole Lauriad ® 58 brivanib 58 TELINTRA R 58 treatment naive genotype 58 non nucleoside HCV 58 IRDye 58 tumors GIST 58 therapeutic monoclonal antibody 58 Ad5FGF 4 58 EVIZON ™ 58 developing TB4 58 Gleevec resistant 58 small molecule thrombopoietin 58 PEG Interferon 58 hypoxia activated prodrug 58 Hepatitis C Viral 58 torezolid 58 PEG IFN 58 myelodysplastic myeloproliferative diseases 58 CRMD# 58 targeted nucleotide prodrug 58 C1INH 58 TBC# 58 VitiGam 58 cortisol synthesis 58 Omacetaxine 58 product candidate Lpathomab 58 itraconazole Sporanox 58 cisplatin gemcitabine 58 cathepsin K inhibitor 58 telomerase inhibitor drug 58 ImmunoBody ® 58 antibiotic candidate Ramoplanin 58 somatostatin analog 58 AzaSite ISV 58 potent inducer 58 dihydrofolate reductase 58 lintuzumab SGN 58 Presents Preclinical 58 dasatinib Sprycel 58 Enterobacter cloacae 58 transthyretin TTR 58 Selective Electrochemical Tumor Ablation 58 aldehyde dehydrogenase ALDH2 deficiency 58 R emtricitabine 58 Personalized Immunotherapy 58 TRX1 58 Epigenomics proprietary 58 nasal powder 58 Orally administered 58 PDE4 inhibitor 58 ALN PCS 58 oral candidiasis 58 NASDAQ PPHM clinical 58 proprietary polysaccharide 58 Darinaparsin 58 hypereosinophilic syndrome 58 Adjuvanted 58 XOMA 3AB 58 CCR5 inhibitor 58 MKC# 58 DEB# 58 generation HCV nucleotide 58 Phase IIb clinical trials 58 XL# anticancer compounds 58 OMP #M# 58 Secretase 58 PEGylated Fab fragment 58 dependent RNA polymerase 58 eligen 58 Solazed 58 adenovirus serotype 58 protein tyrosine phosphatase 1B 58 tests miRview TM 58 indinavir Crixivan 58 ara C 58 including eniluracil ADH 58 treat secondary hyperparathyroidism 58 NanoEmulsion 58 Aurora kinase inhibitor 58 angiotensin analog 58 anticancer therapeutics 58 plasmid encoding 58 infused intravenously 58 integrin inhibitor 58 negative allosteric modulator 58 PANVAC VF 58 humanized monoclonal antibody 58 thrombin receptor 58 pharmacologically active isomer 58 poly ADP ribose polymerase 58 demonstrated antitumor activity 57 Sustiva efavirenz 57 reversible inhibitor 57 DGAT1 inhibitors 57 Cyclosert TM 57 Factor Receptor 57 Annexin V 57 DiLA2 57 PHX# 57 ALK inhibitors 57 volociximab 57 monoclonal antibody mAb 57 oral picoplatin 57 #I TM# 57 Nasdaq XTLB 57 HCV Hepatitis C 57 based pretargeting methods 57 HIV integrase inhibitor 57 hyperimmune 57 oral proteasome inhibitor 57 binds selectively 57 IMPDH inhibitor 57 cladribine Cladribine Tablets 57 nucleotide polymerase inhibitor 57 peptidic compound 57 Curaxin CBLC# 57 matrix metalloproteases 57 investigational antibiotic 57 CD# CEA 57 R Saizen R 57 targeted anticancer biopharmaceuticals 57 muscarinic receptor agonist 57 MKC# MKC# PP 57 inhaled AAT 57 selective orally bioavailable 57 oral anti arrhythmic 57 broad spectrum cephalosporin 57 CG# [003] 57 P#X# antagonist 57 Veronate R 57 Adenoscan R 57 topoisomerase II inhibitor 57 penicillin resistant Streptococcus 57 Cloretazine 57 antimitotic 57 cytomegalovirus immune globulin 57 thalidomide Thalomid 57 Aurora Kinase 57 folate analogue metabolic 57 lead Aganocide compound 57 selectively inhibited 57 p# MAP kinase inhibitor 57 Novasome R 57 TOCOSOL 57 Alexza Staccato 57 acyclovir Lauriad ® 57 Degarelix 57 recombinant biopharmaceutical 57 pegylated alpha interferon 57 covalently bound 57 lexidronam injection 57 XL# XL# 57 Nasdaq MITI biopharmaceutical 57 Kinoid 57 Vaxfectin ® 57 Locked Nucleic Acid 57 pneumocystis pneumonia PCP 57 HuCAL GOLD R 57 Anticalins R 57 purified inactivated vaccine 57 Announces Poster Presentations 57 stable nucleic acid 57 peripherally acting 57 next generation URAT1 57 theranostic 57 dasatinib Sprycel ® 57 IMA# 57 Akt inhibitor 57 selective estrogen receptor modulator 57 abacavir lamivudine 57 pipeline ImmunoGen collaborators 57 receptor monoclonal antibody 57 HBeAg + 57 Pancreas Cancer Vaccine 57 MTP inhibitor 57 Blinatumomab 57 anticancer antiviral 57 commercializing oxidized glutathione 57 Trofex 57 product platforms AZX# 57 Maribavir 57 Tyzeka Sebivo 57 Oral NKTR 57 unpartnered uracil nucleotide analog 57 Viread tenofovir disoproxil fumarate 57 Crixivan 57 AMPK activators 57 novel histone deacetylase 57 AdVac 57 cetuximab Erbitux R 57 LHRH receptor positive 57 Clindamycin 57 ACAPODENE TM 57 includes ecallantide recombinant 57 Micromet proprietary BiTE 57 Submits Biologics License Application 57 world safest multivalent 57 alpha antagonist 57 Luteinizing Hormone Releasing Hormone 57 PTK# 57 PDE4 modulators 57 vaginal candidiasis 57 lead molecular radiotherapeutic 57 irreversible inhibitor 57 androgen receptor antagonist 57 hepatoma 57 potent antiproliferative 57 #mg/#mg 57 Zemiva TM 57 signal transduction inhibitor 57 DNA intercalator 57 Protexia ® 57 pan HDAC inhibitor 57 calcitonin gene related 57 PrevOnco 57 TLR7 agonist 57 Nanobody R 57 ritonavir boosted 57 THR beta agonist 57 candidate deforolimus 57 Recombinant Human 57 CTAP# Capsules 57 Irinotecan 57 KL4 Surfactant 57 methicillin sensitive 57 primary humoral immunodeficiency 57 targeted anticancer therapies 57 COPEGUS therapy 57 SPRYCEL ® 57 mg kg BW 57 ceftazidime 57 Poly ICLC 57 HuMax 57 Squalamine 57 delta opioid receptor 57 AN# novel 57 polymyxin B 57 MOVIPREP R 57 Nasulin ™ 57 Matritech proprietary 56 developing Bicifadine serotonin 56 non resectable metastatic 56 pneumocystis carinii pneumonia 56 ZFP Therapeutics 56 telomerase inhibitor 56 candidates Azedra 56 Ganciclovir 56 glycopeptide 56 HCV protease inhibitors 56 Successfully Completes Phase 56 dihydrochloride 56 anti miRs antisense oligonucleotide 56 containing abacavir 56 immuno therapeutic 56 inhibitor PRO 56 IgM antibodies 56 Cathepsin S 56 ABLYNX 56 plasmid DNA vaccine 56 molecular therapeutics immunotherapies 56 Valtropin 56 Oncolytic 56 staphylococcal vaccine 56 tetracycline antibiotic 56 Vaccine Adjuvant 56 Novolimus 56 Enzastaurin 56 RNA antagonists 56 5 fluorouracil leucovorin 56 NASH Huntington 56 Telatinib 56 isoform selective 56 pralatrexate injection folate analogue 56 enhance ApoA 56 CRTH2 56 selective antagonist 56 Xcytrin R 56 Inc. NASDAQ AVII 56 Onconase 56 5 HT2A inverse 56 Kosan dependence 56 novel immunotherapeutic 56 Files Investigational 56 APR Labtec 56 investigational humanized monoclonal antibody 56 topical ocular 56 CYP#A# substrate 56 FVIIa 56 PRN FDA Approves 56 Pertuzumab 56 HCV NS3 protease 56 Bacteremia 56 ABL inhibitor 56 Lenocta TM 56 fosbretabulin 56 fusion inhibitor 56 Telik logo TELINTRA 56 includes Dideco CarboMedics 56 HBsAg 56 Angiotensin Converting Enzyme 56 toxoids 56 thymidine kinase 56 Enhanze Technology 56 Lauriad ® 56 selective agonist 56 OMP #R# 56 M# rationally 56 NEUGENE R 56 metastatic malignant 56 Bilive R combined 56 Inc. OTCBB ECTE 56 Daptomycin 56 Bilive TM combined 56 Fleximer R 56 oral beclomethasone dipropionate 56 ALN TTR# 56 synthetic retinoid 56 Enhanze TM Technology 56 Sangamo ZFP TF 56 5 lipoxygenase activating 56 Panzem R NCD 56 pneumoniae PRSP 56 CTAP# Injection 56 Fc engineered 56 Gonal f ® 56 MiraWell TM Rapid 56 Pegloticase 56 Imatinib mesylate 56 particle VLP vaccine 56 antisense inhibitors 56 Microsphere 56 Vaxfectin TM formulated 56 Panzem NCD 56 antigen rPA anthrax 56 BUPHENYL R sodium phenylbutyrate 56 oxazolidinone 56 generation purine nucleoside 56 MSCRAMM ® 56 imatinib Gleevec ® 56 Hemopurifier ® 56 fumarate 56 histone deacetylase inhibitor 56 peptibody 56 PowerShares Dynamic Semiconductors 56 Varicella zoster virus 56 CYP#A# isoenzyme 56 PDX pralatrexate 56 inverse agonist 56 phase III isavuconazole 56 tolevamer 56 etanercept Enbrel 56 AmpliChip 56 Janus Kinase 56 Inc. Nasdaq MITI 56 Tß4 56 Phase 2b Clinical Trial 56 Licenses Novel 56 potent suppressor 56 edifoligide 56 VERSANT 56 inhaled formulation 56 FUSILEV enhances 56 relapsed leukemia 56 enhanced skin permeation 56 immunomodulatory therapy 56 Myocet 56 oral renin inhibitor 56 please visit http:/www.vandapharma.com 56 intravenous AAT 56 Nicotine Conjugate Vaccine 56 stem cell mobilizer 56 Preclinical studies suggest 56 forodesine 56 selective receptor agonist 56 delta gamma agonist 56 fibrosis IPF 56 Ozarelix 56 Sphingomab TM 56 candidate REP# 56 Complicated Skin 56 abacavir Ziagen 56 aurora kinase inhibitor 56 JAK2 inhibitor 56 Aganocide 56 tumor activated prodrug 56 TNF Tumor Necrosis Factor 56 beta 1a 56 M2 subunit 56 CCR1 56 Oral Fluid 56 RhuDex ® 56 using Innocoll proprietary 56 molecular imaging radiopharmaceuticals 56 BiTE ® 56 novel orally bioavailable 56 immunotherapeutic approaches 56 Annamycin 56 Silodosin 56 histone deacetylase HDAC 56 GLP toxicology studies 56 MT# MEDI 56 VANOS TM 56 proteasome inhibitor 56 targeted antifolate 56 K. pneumoniae 56 NS5B 56 Apoptone HE# 56 Multiple Myeloma MM 56 orally bioavailable 56 humanized interleukin 6 56 Humanized Anti 56 reverse transcriptase protease 56 oral JAK1 56 ® lenalidomide 56 Angiocept 56 colon carcinoma 56 oral talactoferrin 56 includes TOLAMBA TM 56 Macrolide 56 ALTROPANE R 56 CCR5 tropic 56 patented DepoVax TM 56 E2F Decoy 56 bevacizumab Avastin R 56 Bosutinib 56 acting neuraminidase inhibitor 56 JAK inhibitors 56 neuronal nicotinic receptor NNR 56 TKM ApoB 56 Xeloda ® 56 anti CD3 56 NYSE Amex AEN 56 brand ciclesonide HFA 56 HER1 56 ARG# 56 receptor inhibiting monoclonal 56 GHRH 56 novel synthetic PEGylated 56 hPTH #-# 56 humanized antibody 56 Pfenex Expression Technology 56 Budesonide foam crofelemer 56 anti secretory 56 vinca alkaloid 56 taxane derivative 56 Intradermal 56 manages freestanding psychiatric 56 Retisert ® 56 Completes Dosing 56 amprenavir 56 DOXIL R 56 Oxytrex TM 56 Maxy G# 56 meropenem 56 Transdermal Patch 56 TRACON Pharmaceuticals 56 Chimigen TM 56 Survivin antagonist 56 midstage trials 55 selective kinase inhibitor 55 novel synthetic peptide 55 Neugene 55 RNAi therapeutic targeting 55 Aplidin 55 cromolyn sodium 55 TMC# [002] 55 semi synthetic lipoglycopeptide 55 Pruvel 55 VitiGam TM 55 Progressive Multifocal Leukoencephalopathy 55 SGLT 55 HuMax Inflam 55 MBRX 55 parenterally administered 55 romazarit 55 oncolytic 55 Protease Inhibitors 55 cardio renal 55 modified glutathione analog 55 orally inhaled 55 Intercell investigational 55 XOMA 3AB biodefense 55 DuraSite ® 55 Namenda Memantine HCl 55 sapacitabine CYC# 55 ADCC enhanced 55 gp# protein [002] 55 abacavir sulfate lamivudine 55 2 inhibitor CYT# 55 isoenzyme 55 targeting PCSK9 55 huC# DM4 55 EliA 55 Earns Milestone Payment 55 lung pancreatic 55 immunoconjugate 55 PORxin TM 55 pan histone deacetylase 55 ZFN TM 55 5 HT4 55 OHR/AVR# 55 DNA methyltransferase inhibitors 55 ergot derivatives 55 PSN# [002] 55 alvespimycin 55 gefitinib Iressa 55 RhuDex R 55 monoclonal anti 55 mitoxantrone plus 55 ARIKACE ™ 55 non resectable 55 macrolide antibiotic 55 Preclinical Data 55 drug conjugates ADCs 55 vivo toxicology 55 antiangiogenic agent 55 Empatic ™ 55 sitagliptin metformin 55 4SC AG ISIN DE# 55 Aganocide ® 55 anti CTLA 55 gamma secretase inhibitor 55 development peramivir neuraminidase 55 uremic pruritus 55 Curaxin 55 metaglidasen 55 treat chronic sinusitis 55 TKB# 55 immuno modulatory 55 immune modulator 55 Monoclonal 55 potent topoisomerase II 55 Lixivaptan 55 Bruton tyrosine kinase 55 Initiates Phase 55 Potelligent Technology 55 vaccine GRNVAC1 55 midstage clinical 55 lipid particle 55 immunotoxin 55 NeoLipid R 55 potent stimulator 55 BCR ABL inhibitors 55 HIV treatments Reyataz 55 oral salmon calcitonin 55 Systemic Delivery 55 HCV polymerase inhibitor 55 MorphoSys proprietary 55 fluoroquinolone class 55 ciprofloxacin hydrochloride 55 TLR8 agonist 55 syngeneic 55 Shows Statistically Significant 55 receptor modulators 55 nucleoside reverse transcriptase inhibitor 55 Olaparib 55 Syncria albiglutide 55 Monopril 55 Selective Inhibitor 55 im peramivir 55 phorbol 55 selective phosphodiesterase 55 MediGene focuses 55 Plavix clopidogrel bisulfate 55 Onalta 55 protein transduction 55 Transfersome ® 55 Novasome R adjuvant 55 Klebsiella pneumonia 55 Novel Oral 55 visit www.genmab.com 55 R sorafenib tablets 55 epothilones 55 nasal carriage 55 vectored vaccine 55 investigational immunotherapy 55 TÎ ² 4 55 somatostatin receptor 55 Occlusin TM 55 FDA Clears 55 mesylate 55 Drug Candidate 55 GVAX R 55 Marqibo TM 55 peptide conjugated 55 diagnostic biomarker 55 approved incretin mimetic 55 TO AVOID PREGNANCY WHILE 55 gastro intestinal inflammation 55 novel topoisomerase 55 Kahalalide F 55 M#V 55 INVANZ 55 CDK inhibitor 55 addressing idiopathic pulmonary 55 AFFITOME R 55 Streptococcus pneumonia 55 tkRNAi 55 mitogen activated ERK kinase 55 programs visit http:/www.bionovo.com 55 generation URAT1 inhibitor 55 HepDirect R 55 Completes Enrollment 55 JAK inhibitor 55 levoleucovorin 55 drug conjugate ADC 55 DepoVax ™ 55 synthase TS 55 tissue transglutaminase 55 nilotinib Tasigna ® 55 reverse transcriptase inhibitors 55 receptor antagonism 55 Submits NDA 55 Intravitreal 55 outlicensed 55 Cumulase 55 oral immunomodulatory 55 targeted tyrosine kinase 55 PF # [002] 55 humanized anti 55 selectively inhibiting 55 endothelin receptor 55 cyclophosphamide methotrexate 55 ospemifene 55 Bordetella pertussis 55 Commences Phase 55 Patients Treated With 55 drug conjugate 55 Spiegelmer 55 MedPulser 55 tuberculosis hepatitis B 55 unresectable inoperable 55 Posiphen TM 55 telomerase therapeutic 55 rifabutin 55 adult mesenchymal stem 55 histamine dihydrochloride 55 adalimumab Humira 55 administered intramuscularly 55 JAK2 inhibitors 55 RNAi therapeutic targeting PCSK9 55 FDA Accepts 55 investigational antiplatelet agent 55 hematopoietic progenitor cells 55 uricase 55 siRNA therapeutic 55 mTOR mammalian target 55 cytotoxic T lymphocyte 55 Convivia TM 55 small molecule Hedgehog 54 topical anti infective 54 OXIGON TM 54 DOS# 54 Janus kinase 54 M. anisopliae 54 SAR# [004] 54 glycoprotein GP IIb IIIa 54 adrenoceptor agonist 54 ALN TTR 54 inhibit oxidative stress 54 secretory phospholipase A2 54 RhuDex TM 54 recombinant insulin 54 antisense drug 54 generation oxazolidinone 54 HuCAL antibodies 54 MetroGel 54 sublingual tablet formulation 54 Epothilone D 54 PSN# [001] 54 Adjunctive 54 Protein Kinase C 54 Micromet BiTE 54 Staphylococcus epidermidis 54 BIM #A# 54 sulfamethoxazole 54 NicVAX TM 54 beta lactam antibiotic 54 Evoltra ® 54 treat refractory angina 54 intravesical instillation 54 prostate cancer benign prostatic 54 R MSCRAMM 54 Interferon gamma 54 Nasdaq PPHM clinical 54 astemizole 54 treat atopic dermatitis 54 Genentech Rituxan 54 topical antifungal 54 BD GeneOhm 54 chronic HCV infection 54 VivaGel TM 54 CYT# vascular disrupting 54 dexamethasone Decadron 54 Anavex #-# 54 liquid chromatography tandem 54 receptor blocker 54 Escherichia coli Klebsiella pneumoniae 54 Epivir R 54 Allovectin 7 54 HuCAL antibody 54 anaplastic lymphoma kinase ALK 54 EndoTAG TM 54 triggers apoptosis programmed 54 Anti Factor VIII 54 GeoVax vaccine 54 NS5A 54 Transdermal Delivery 54 radiotherapeutic 54 AdhTAP 54 Rimantadine 54 selectively activates 54 Glucagon Like Peptide 54 investigational monoclonal antibody 54 Raf kinase 54 LB# [003] 54 clinical biomarkers immunogenicity 54 XmAb 54 Variant Creutzfeldt Jakob Disease 54 AEG# 54 Inc. Nasdaq VIAP 54 Additionally MorphoSys 54 methicillin susceptible Staphylococcus aureus 54 Protexia R 54 apoptosis inducers 54 recombinant spider silk 54 Levoleucovorin 54 Proellex TM 54 nephropathic cystinosis 54 Bruton tyrosine kinase Btk 54 adenoviral 54 cefotaxime